Michael Geraghty - 06 Jul 2022 Form 4 Insider Report for Apyx Medical Corp (APYX)

Reporting relationship: Director
Issuer ticker: APYX
Reported as of: 06 Jul 2022
Net transaction value: +$10,160
SEC form: 4
Accepted by SEC: 11 Jul 2022, 10:22:31 UTC
Prior SEC filing: 19 May 2022
Next SEC filing: 17 Aug 2022
Source filing: View source filing
Reporting owner signature: /s/ Michael Geraghty

Key filing fact

Michael Geraghty filed Form 4 for Apyx Medical Corp (APYX) on 11 Jul 2022.

Key facts

This page summarizes Michael Geraghty's Form 4 filing for Apyx Medical Corp (APYX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 11 Jul 2022, 10:22.

Change

Previous filing in this sequence was filed on 19 May 2022.
Current net transaction value: +$10,160.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

APYX transaction

Common Stock

Options Exercise

Transaction value: $10,160
Shares: +4,000
Change %: +30%
Price: $2.54
Shares after: 17,500
Date: 06 Jul 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

APYX transaction Derivative

Stock Option (Option to Buy)

Options Exercise

Transaction value: $0
Shares: -4,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 Jul 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,000
Exercise price: $2.54
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reporting Person was granted a stock option that vested and became exercisable over 3 years at a rate of 33.33% of the option on the anniversary date of each succeeding year.